← Leaderboards
Peter Philip Reese
University Of Pennsylvania
$11,077,710
Attributed
$24,978,089
Total exposure
13
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.9M · FY2006–25$5M$3.8M$2.5M$1.3M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$24,978,089 · 13
By mechanism
U01$13,037,828 · 2
R01$9,466,451 · 5
K24$670,830 · 1
K23$658,335 · 1
R21$460,858 · 1
U34$362,250 · 1
Top collaborators
- David Seth Goldberg10 shared
- Iwan Barankay9 shared
- Kevin G Volpp9 shared
- Gregory Edward Tasian8 shared
- Douglas Earl Schaubel5 shared
- Sarah J Ratcliffe4 shared
- Deirdre Sawinski2 shared
- Elisa J Gordon1 shared
Most similar at University Of Pennsylvania
Same institution · by research overlap
- David Seth Goldberg$7,222,905
- Ali Naji$46,943,355
- Matthew Howard Levine$3,300,352
- Jason H Karlawish$15,923,629
- Wenchao Song$30,516,555
Others in their field
Top investigators on “Kidney”
- Jeffrey P Krischer · University Of South Florida$540,222,210
- John M Lachin · George Washington University$155,894,464
- David M Nathan · Massachusetts Institute Of Technology$127,229,266
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$111,521,899
- David Heimbrook · Leidos Biomedical Research, Inc.$83,221,586
- Peter Scott Heeger · Case Western Reserve University$80,562,246
Research focus
KidneyTransplantationKidney TransplantationOrganLifeUnited StatesPharmaceutical PreparationsWaiting ListsProgramsQuality Of LifeCessation Of LifeElderlyPrevalenceHigh RiskFinancial IncentiveMorbidity - Disease RateResearch PersonnelCaringBehavioralEnd Stage Renal FailureGrantAllograftingAdultKidney Allograft
Grant awards (46)
A trial of transplanting Hepatitis C-viremic kidneys into Hepatitis C-Negative kidney recipients (THINKER-NEXT)$1,469,793
U01 · FY2025 · DK
Assessing Multi-level Barriers to Living Liver Donor Transplantation$251,516
R01 · FY2025 · DK
A trial of transplanting Hepatitis C-viremic kidneys into Hepatitis C-Negative kidney recipients (THINKER-NEXT)$1,514,838
U01 · FY2024 · DK
Harnessing Behavior to Decrease Urinary Stone Disease Morbidity Research Project$485,000
U01 · FY2024 · DK
A trial of transplanting Hepatitis C-viremic kidneys into Hepatitis C-Negative kidney recipients (THINKER-NEXT)$1,613,436
U01 · FY2023 · DK · contact PI
Developing High-Quality Tools to Characterize Allograft Quality, Predict Transplant Outcomes and Expand Access to Kidney and Liver Transplantation$506,377
R01 · FY2023 · DK · contact PI
Harnessing Behavior to Decrease Urinary Stone Disease Morbidity Research Project$503,966
U01 · FY2023 · DK
Mentored research in solid organ transplantation: outcomes using organs from Hepatitis C virus infected donors for uninfected recipients$134,166
K24 · FY2023 · AI · contact PI
A trial of transplanting Hepatitis C-viremic kidneys into Hepatitis C-Negative kidney recipients (THINKER-NEXT)$1,493,330
U01 · FY2022 · DK · contact PI
Harnessing Behavior to Decrease Urinary Stone Disease Morbidity Research Project$689,726
U01 · FY2022 · DK
Developing High-Quality Tools to Characterize Allograft Quality, Predict Transplant Outcomes and Expand Access to Kidney and Liver Transplantation$546,219
R01 · FY2022 · DK · contact PI
Mentored research in solid organ transplantation: outcomes using organs from Hepatitis C virus infected donors for uninfected recipients$134,166
K24 · FY2022 · AI · contact PI
A trial of transplanting Hepatitis C-viremic kidneys into Hepatitis C-Negative kidney recipients (THINKER-NEXT)$1,676,144
U01 · FY2021 · DK · contact PI
Developing High-Quality Tools to Characterize Allograft Quality, Predict Transplant Outcomes and Expand Access to Kidney and Liver Transplantation$479,002
R01 · FY2021 · DK · contact PI
Mentored research in solid organ transplantation: outcomes using organs from Hepatitis C virus infected donors for uninfected recipients$134,166
K24 · FY2021 · AI · contact PI
Harnessing Behavior to Decrease Urinary Stone Disease Morbidity Research Project$738,143
U01 · FY2020 · DK
Developing High-Quality Tools to Characterize Allograft Quality, Predict Transplant Outcomes and Expand Access to Kidney and Liver Transplantation$525,678
R01 · FY2020 · DK · contact PI
Mentored research in solid organ transplantation: outcomes using organs from Hepatitis C virus infected donors for uninfected recipients$134,166
K24 · FY2020 · AI · contact PI
Comparative effectiveness of process and outcomes incentives for lipid management$763,674
R01 · FY2019 · HL · contact PI
Harnessing Behavior to Decrease Urinary Stone Disease Morbidity Research Project$716,883
U01 · FY2019 · DK
A trial of transplanting Hepatitis C kidneys into Hepatitis C-Negative kidney recipients$362,250
U34 · FY2019 · DK · contact PI
Mentored research in solid organ transplantation: outcomes using organs from Hepatitis C virus infected donors for uninfected recipients$134,166
K24 · FY2019 · AI · contact PI
Comparative effectiveness of process and outcomes incentives for lipid management$763,867
R01 · FY2018 · HL
Harnessing Behavior to Decrease Urinary Stone Disease Morbidity Research Project$685,019
U01 · FY2018 · DK
Waiting List and Kidney Transplant Outcomes for Patients with Hepatitis C Infection$202,679
R21 · FY2018 · DK · contact PI
Comparative effectiveness of process and outcomes incentives for lipid management$781,005
R01 · FY2017 · HL
Harnessing Behavior to Decrease Urinary Stone Disease Morbidity Research Project$704,655
U01 · FY2017 · DK
Waiting List and Kidney Transplant Outcomes for Patients with Hepatitis C Infection$258,179
R21 · FY2017 · DK · contact PI
Harnessing Behavior to Decrease Urinary Stone Disease Morbidity Research Project$746,895
U01 · FY2016 · DK
A randomized trial of cognitive vs. behavioral incentives to induce sustained healthy oral hygiene habits and improve oral health$240,000
R34 · FY2016 · DE
Comparative effectiveness of process and outcomes incentives for lipid management$771,267
R01 · FY2015 · HL
A Randomized Controlled Trial of Incentives for Habit Formation$388,415
R01 · FY2015 · AG
Comparative effectiveness of process and outcomes incentives for lipid management$808,240
R01 · FY2014 · HL
A Randomized Controlled Trial of Incentives for Habit Formation$652,522
R01 · FY2014 · AG
Age, functional status, and survival benefit from kidney transplantation$208,800
R01 · FY2014 · DK · contact PI
A Randomized Controlled Trial of Incentives for Habit Formation$673,662
R01 · FY2013 · AG
Age, functional status, and survival benefit from kidney transplantation$201,493
R01 · FY2013 · DK · contact PI
A Randomized Controlled Trial of Incentives for Habit Formation$535,914
R01 · FY2012 · AG
Age, functional status, and survival benefit from kidney transplantation$208,800
R01 · FY2012 · DK · contact PI
Age, functional status, and survival benefit from kidney transplantation$400,000
R01 · FY2011 · DK · contact PI
Measuring Living Kidney Transplantation at Renal Transplant Centers$131,667
K23 · FY2011 · DK · contact PI
Measuring Living Kidney Transplantation at Renal Transplant Centers$131,667
K23 · FY2010 · DK · contact PI
Measuring Living Kidney Transplantation at Renal Transplant Centers$131,667
K23 · FY2009 · DK · contact PI
Measuring Living Kidney Transplantation at Renal Transplant Centers$131,667
K23 · FY2008 · DK · contact PI
Measuring Living Kidney Transplantation at Renal Transplant Centers$131,667
K23 · FY2007 · DK · contact PI
Predictors of Living Kidney Donor Recruitment$81,537
F32 · FY2006 · DK · contact PI